B. A. Trofimov et al.
FULL PAPER
anal (3b; 0.072 g, 1 mmol), and 1-methylimidazole (1a; 0.082 g,
1 mmol) (20–25 °C, 24 h) enol ether 4e (0.122 g, 43%) was obtained
3 JH , H = 7.1 Hz, 3 H, C6 -(CH2 )2 -CH3 ] ppm. 1 3 C NMR
(100.62 MHz, CDCl3): δ = 171.2 (C-8), 143.9 (C-2), 133.8 (Ci, Ph),
131.1 (Cp, Ph), 128.9 (Cm, Ph), 127.7 (C-4), 127.0 (Co, Ph), 119.9
(C-5), 116.7 (C-10, CN), 77.9 (C-9), 77.1 (C-6), 40.6 (N-CH2-), 35.4
(C6-CH2-), 18.6 (C6-CH2-CH2-), 16.3 (N-CH2-CH3), 13.5 [C6-
(CH)2-CH3] ppm. C18H21N3O (295.38): calcd. C 73.19, H 7.17, N
14.23; found C 72.75, H 6.90, N 14.45.
as a yellow oil. IR (microlayer): ν = 3065, 3034, 2962, 2935, 2874,
˜
2216, 1612, 1576, 1493, 1463, 1448, 1324, 1283, 1250, 1184, 1121,
1087, 1057, 1027, 988, 922, 760, 698, 662, 525 cm–1 1H NMR
.
(400.13 MHz, CDCl3): δ = 7.50–7.40 (m, 5 H, Ph), 6.92 (s, 1 H, 4-
3
H), 6.85 (s, 1 H, 5-H), 5.57 (t, JH6,CH = 6.4 Hz, 1 H, 6-H), 4.93
2
(s, 1 H, 9-H), 3.77 (s, 3 H, N-CH3), 2.10 (m, 2 H, C6-CH2-), 1.40–
1.26 (m, 2 H, C6-CH2-CH2-), 0.88 [t, JH,H = 7.1 Hz, 3 H, C6-
(Z)-3-{[(1-Ethyl-1H-imidazol-2-yl)pentyl]oxy}-3-phenyl-2-propene-
nitrile (4i): Analogously, from acetylene 2b (0.127 g, 1 mmol), n-
pentanal (3c; 0.086 g, 1 mmol), and 1-ethylimidazole (1b; 0.096 g,
1 mmol) (20–25 °C, 24 h) enol ether 4i (0.166 g, 54%) was obtained
3
(CH2)2-CH3] ppm. 13C NMR (100.62 MHz, CDCl3): δ = 171.5 (C-
8), 144.7 (C-2), 134.0 (Ci, Ph), 131.4 (Cp, Ph), 129.1 (Cm, Ph), 127.8
(C-4), 127.3 (Co, Ph), 122.8 (C-5), 116.8 (C-10, CN), 78.0 (C-9),
77.1 (C-6), 36.0 (C6-CH2-), 33.8 (N-CH3), 18.7 (C6-CH2-CH2-),
13.8 [C6-(CH2)2-CH3] ppm. 15N NMR (40.55 MHz, CDCl3): δ =
–120.0 (N-3), –125.1 (CN-10), –222.9 (N-1) ppm. C17H19N3O
(281.36): calcd. C 72.57, H 6.81, N 14.91; found C 72.05, H 6.80,
N 14.45.
as a light-brown oil. IR (microlayer): ν = 3065, 2958, 2933, 2872,
˜
2216, 1608, 1576, 1492, 1466, 1448, 1379, 1331, 1277, 1258, 1180,
1
1158, 1090, 1028, 992, 919, 896, 849, 761, 697, 662, 526 cm–1. H
NMR (400.13 MHz, CDCl3): δ = 7.50–7.40 (m, 5 H, Ph), 6.98 (s,
3
1 H, 4-H), 6.93 (s, 1 H, 5-H), 5.68 (t, JH6,CH = 6.4 Hz, 1 H, 6-
2
H), 4.94 (s, 1 H, 9-H), 4.15 (q, 3JH,H = 7.1 Hz, 2 H, N-CH2-), 2.25–
2.14 (m, 2 H, C6-CH2-), 1.39 (t, 3 H, N-CH2-CH3), 1.33–1.17 [m,
4 H, C6-CH2-(CH2)2-], 0.83 [t, JH,H = 7.1 Hz, 3 H, C6-(CH2)3-
(Z)-3-{[(1-Methyl-1H-imidazol-2-yl)pentyl]oxy}-3-phenyl-2-propene-
nitrile (4f): Analogously, from acetylene 2b (0.127 g, 1 mmol), n-
pentanal (3c; 0.086 g, 1 mmol), and 1-methylimidazole (1a; 0.082 g,
1 mmol) (20–25 °C, 24 h) enol ether 4f (0.091 g, 31%) was obtained
3
CH3] ppm. 13C NMR (100.62 MHz, CDCl3): δ = 170.6 (C-8), 143.6
(C-2), 132.58 (Ci, Ph), 130.9 (Cp, Ph), 128.4 (Cm, Ph), 127.7 (C-4),
126.7 (Co, Ph), 119.7 (C-5), 116.2 (C-10, CN), 76.8 (C-9), 76.3 (C-
6), 40.7 (N-CH2-), 33.2 (C6-CH2-), 26.8 (C6-CH2-CH2-), 21.9 [C6-
(CH2)2-CH2-], 16.1 (N-CH2-CH3), 13.4 [C6-(CH2)3-CH3] ppm.
C19H23N3O (309.41): calcd. C 73.76, H 7.49, N 13.58; found C
73.25, H 7.28, N 13.23.
as a yellow oil. IR (microlayer): ν = 3064, 2958, 2932, 2872, 2216,
˜
1612, 1576, 1493, 1466, 1448, 1413, 1330, 1282, 1248, 1183, 1088,
1028, 992, 919, 760, 699, 661, 525 cm–1. 1H NMR (400.13 MHz,
CDCl3): δ = 7.50–7.40 (m, 5 H, Ph), 6.83 (s, 1 H, 4-H), 6.76 (s, 1
3
H, 5-H), 5.58 (t, JH6,CH = 6.4 Hz, 1 H, 6-H), 4.91 (s, 1 H, 9-H),
2
(Z)-3-[(1-Isobutyl-1H-imidazol-2-yl)ethoxy]-3-phenyl-2-propeneni-
trile (4j): Analogously, from acetylene 2b (0.127 g, 1 mmol), ethanal
(3a; 0.132 g, 3 mmol), and 1-isobutylimidazole (1c; 0.124 g,
1 mmol) (20–25 °C, 24 h) enol ether 4j (0.182 g, 62%) was obtained
3.79 (s, 3 H, N-CH3), 2.25–2.12 (m, 2 H, C6-CH2-), 1.36–1.18 [m,
4 H, C6-CH2-(CH2)2-], 0.83 [t, JH,H = 7.1 Hz, 3 H, C6-(CH2)3-
3
CH3] ppm. 13C NMR (100.62 MHz, CDCl3): δ = 171.2 (C-8), 144.5
(C-2), 132.9 (Ci, Ph), 131.3 (Cp, Ph), 128.9 (Cm, Ph), 127.7 (C-4),
127.2 (Co, Ph), 122.7 (C-5), 116.7 (C-10, CN), 77.8 (C-9), 77.0 (C-
6), 33.5 (N-CH3), 33.5 (C6-CH2-), 27.2 (C6-CH2-CH2-), 22.3 [C6-
(CH2)2-CH2-], 13.8 [C6-(CH2)3-CH3] ppm. C18H20N3O (295.38):
calcd. C 73.19, H 7.17, N 14.23; found C 73.17, H 7.08, N 14.13.
as a light-brown oil. IR (microlayer): ν = 3066, 2964, 2936, 2874,
˜
2215, 1650, 1606, 1575, 1491, 1469, 1448, 1376, 1344, 1306, 1277,
1254, 1183, 1151, 1109, 1090, 1062, 1014, 978, 921, 896, 841, 762,
733, 697, 666, 533 cm–1. 1H NMR (400.13 MHz, CDCl3): δ = 7.50–
7.30 (m, 5 H, Ph), 7.00 (s, 1 H, 4-H), 6.89 (s, 1 H, 5-H), 6.02 (q,
(Z)-3-[(1-Ethyl-1H-imidazol-2-yl)ethoxy]-3-phenyl-2-propenenitrile
(4g): Analogously, from acetylene 2b (0.127 g, 1 mmol), ethanal
(3a; 0.132 g, 3 mmol), and 1-ethylimidazole (1b; 0.096 g, 1 mmol)
(20–25 °C, 24 h) enol ether 4g (0.132 g, 49%) was obtained as a
3JH6,CH = 6.4 Hz, 1 H, 6-H), 5.09 (s, 1 H, 9-H), 3.81–3.79 (m, 2
3
3
H, N-CH2-), 2.03–1.96 (m, 1 H, N-CH2-CH-), 1.81 (d, JH,H
=
3
6.8 Hz, 3 H, C6-CH3), 0.88 [d, JH,H = 6.8 Hz, 6 H, N-CH2-CH-
(CH3)2] ppm. 13C NMR (100.62 MHz, CDCl3): δ = 169.1 (C-8),
144.6 (C-2), 132.9 (Ci, Ph), 130.9 (Cp, Ph), 128.3 (Cm, Ph), 127.4
(C-4), 126.4 (Co, Ph), 120.8 (C-5), 116.4 (C-10, CN), 75.5 (C-9),
70.9 (C-6), 52.9 (N-CH2-), 29.6 (N-CH2-CH-), 19.4 (C6-CH3), 18.4
[N-CH2-CH-(CH3)2] ppm. C18H21N3O (295.38): calcd. C 73.19, H
7.17, N 14.23; found C 73.72, H 7.15, N 14.30.
light-brown oil. IR (microlayer): ν = 3066, 2984, 2938, 2214, 1651,
˜
1606, 1569, 1492, 1465, 1448, 1378, 1347, 1305, 1286, 1257, 1183,
1150, 1114, 1088, 1059, 1025, 963, 920, 896, 850, 760, 697, 666,
1
521 cm–1. H NMR (400.13 MHz, CDCl3): δ = 7.60–7.40 (m, 5 H,
3
Ph), 6.97 (s, 1 H, 4-H), 6.92 (s, 1 H, 5-H), 5.92 (q, JH6,CH
=
6.4 Hz, 1 H, 6-H), 5.03 (s, 1 H, 9-H), 4.14 (q, 3JH,H = 7.1 Hz, 22H,
N-CH2-), 1.76 (s, 3 H, C6-CH3), 1.38 (t, 3 H, N-CH2-CH3) ppm.
13C NMR (100.62 MHz, CDCl3): δ = 169.8 (C-8), 144.4 (C-2),
132.8 (Ci, Ph), 131.1 (Cp, Ph), 128.5 (Cm, Ph), 127.6 (C-4), 126.6
(Co, Ph), 120.1 (C-5), 116.4 (C-10, CN), 76.6 (C-9), 72.1 (C-6), 40.8
(N-CH2-), 18.7 (C6-CH3), 16.1 (N-CH2-CH3) ppm. C16H17N3O
(267.33): calcd. C 71.89, H 6.41, N 15.72; found C 71.40, H 6.31,
N 15.74.
(Z)-3-[(1-Isobutyl-1H-imidazol-2-yl)butoxy]-3-phenyl-2-propeneni-
trile (4k): Analogously, from acetylene 2b (0.127 g, 1 mmol), n-but-
anal (3b; 0.072 g, 1 mmol), and 1-isobutylimidazole (1c; 0.124 g,
1 mmol) (20–25 °C, 24 h) enol ether 4k (0.189 g, 59 %) was ob-
tained as a brown oil. IR (microlayer): ν = 3065, 2963, 2934, 2874,
˜
2216, 1605, 1575, 1491, 1468, 1448, 1370, 1344, 1323, 1279, 1254,
1180, 1154, 1095, 1027, 982, 950, 932, 894, 756, 697, 663, 526 cm–1.
1H NMR (400.13 MHz, CDCl3): δ = 7.45–7.32 (m, 5 H, Ph), 7.01
3
(Z)-3-[(1-Ethyl-1H-imidazol-2-yl)butoxy]-3-phenyl-2-propenenitrile (s, 1 H, 4-H), 6.89 (s, 1 H, 5-H), 5.81 (t, JH6,CH = 6.4 Hz, 1 H, 6-
2
(4h): Analogously, from acetylene 2b (0.127 g, 1 mmol), n-butanal
(3b; 0.072 g, 1 mmol), and 1-ethylimidazole (1b; 0.096 g, 1 mmol)
(20–25 °C, 24 h) enol ether 4h (0.160 g, 54%) was obtained as a
H), 5.01 (s, 1 H, 9-H), 3.83–3.80 (m, 2 H, N-CH2-), 2.24–2.15 (m,
2 H, C6-CH2-), 2.04–1.97 (m, 1 H, N-CH2-CH-), 1.44–1.26 (m, 2
H, C6-CH2-CH2-), 0.92–0.87 [m, 9 H, N-CH2-CH-(CH3)2 and C6-
yellow oil. IR (microlayer): ν = 3064, 2963, 2930, 2874, 2855, 2218, (CH2)2-CH3] ppm. 13C NMR (100.62 MHz, CDCl3): δ = 170.5 (C-
˜
1612, 1575, 1492, 1448, 1406, 1379, 1280, 1260, 1178, 1160, 1101,
8), 144.4 (C-2), 133.2 (Ci, Ph), 131.3 (Cp, Ph), 128.8 (Cm, Ph), 128.0
(C-4), 127.1 (Co, Ph), 121.1 (C-5), 116.9 (C-10, CN), 76.1 (C-9),
1
1027, 965, 918, 760, 695 cm–1. H NMR (400.13 MHz, CDCl3): δ
= 7.50–7.40 (m, 5 H, Ph), 6.98 (s, 1 H, 4-H), 6.93 (s, 1 H, 5-H), 75.5 (C-6), 53.4 (N-CH2-), 35.6 (C6-CH2-), 30.1 (N-CH2-CH-), 19.8
3
5.67 (t, JH6,CH = 6.4 Hz, 1 H, 6-H), 4.93 (s, 1 H, 9-H), 4.20 (q, [N-CH2-CH-(CH3)2], 18.4 (C6-CH2-CH2-), 13.8 [C6-(CH2)2-CH3]
3JH,H = 6.8 Hz,22 H, N-CH2-), 2.25–2.12 (m, 2 H, C6-CH2-), 1.43– ppm. C20H25N3O (323.44): calcd. C 74.27, H 7.79, N 12.99; found
1.25 (m, 2 H, C6-CH2-CH2-), 1.36 (t, 3 H, N-CH2-CH3), 0.88 [t, C 74.42, H 7.56, N 12.86.
1776
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 1772–1777